Hydrochlorothiazide; Telmisartan Patent Expiration
Hydrochlorothiazide; Telmisartan is Used for lowering high blood pressure. It was first introduced by Boehringer Ingelheim
Hydrochlorothiazide; Telmisartan Patents
Given below is the list of patents protecting Hydrochlorothiazide; Telmisartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Micardis Hct | US6358986 | Polymorphs of telmisartan |
Jan 10, 2020
(Expired) | Boehringer Ingelheim |
| Micardis Hct | US5591762 | Benzimidazoles useful as angiotensin-11 antagonists |
Jan 07, 2014
(Expired) | Boehringer Ingelheim |
Hydrochlorothiazide; Telmisartan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List